Dapagliflozin is associated with improved glycaemic control and weight reduction at 44 months of follow-up in a secondary care diabetes clinic in the UK
| Date first appeared online | 26/03/2020 |
| DOI | 10.1016/j.dsx.2020.03.007 |
| Authors | Stephens J. |
| Journal Name | Diabetes & Metabolic Syndrome: Clinical Research & Reviews |
| Volume | 14 |
Documents
- 53936.pdf , Book, Released under the terms of a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND).